Immuneering Corp - Class A common stock, par value $0.001 per share (IMRX)
CUSIP: 45254E107
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Class A common stock, par value $0.001 per share
- Shares outstanding
- 66,027,379
- Total 13F shares
- 12,489,185
- Share change
- +386,491
- Total reported value
- $199,826,000
- Price per share
- $16.17
- Number of holders
- 36
- Value change
- +$5,452,786
- Number of buys
- 23
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 45254E107?
CUSIP 45254E107 identifies IMRX - Immuneering Corp - Class A common stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45254E107:
Top shareholders of IMRX - Immuneering Corp - Class A common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4.7%
|
3,114,025
|
$81,231,000 | — | 30 Sep 2021 | |
| Cormorant Asset Management, LP |
13F
|
Company |
3.4%
|
2,252,626
|
$58,451,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.1%
|
2,055,459
|
$52,403,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.3%
|
1,524,374
|
$40,472,000 | — | 30 Sep 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.7%
|
1,089,816
|
$28,935,000 | — | 30 Sep 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1%
|
681,051
|
$18,082,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.52%
|
343,601
|
$9,123,000 | — | 30 Sep 2021 | |
| FMR LLC |
13F
|
Company |
0.38%
|
250,000
|
$6,638,000 | — | 30 Sep 2021 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.3%
|
200,000
|
$5,310,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
122,319
|
$3,247,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.15%
|
101,202
|
$2,687,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.14%
|
89,788
|
$2,384,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.11%
|
72,612
|
$1,928,000 | — | 30 Sep 2021 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.06%
|
40,000
|
$1,062,000 | — | 30 Sep 2021 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.05%
|
34,296
|
$911,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
20,599
|
$547,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.03%
|
20,236
|
$538,000 | — | 30 Sep 2021 | |
| Ghisallo Capital Management LLC |
13F
|
Company |
0.02%
|
15,000
|
$398,000 | — | 30 Sep 2021 | |
| Kore Private Wealth LLC |
13F
|
Company |
0.02%
|
14,100
|
$374,000 | — | 30 Sep 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.02%
|
13,149
|
$349,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.02%
|
11,760
|
$312,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
6,703
|
$178,000 | — | 30 Sep 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
4,752
|
$126,000 | — | 30 Sep 2021 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
4,526
|
$120,000 | — | 30 Sep 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
4,468
|
$119,000 | — | 30 Sep 2021 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.01%
|
3,719
|
$98,739 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
3,167
|
$84,000 | — | 30 Sep 2021 | |
| METROPOLITAN LIFE INSURANCE CO/NY |
13F
|
Company |
0%
|
2,814
|
$74,712 | — | 30 Sep 2021 | |
| STRS OHIO |
13F
|
Company |
0%
|
1,900
|
$50,000 | — | 30 Sep 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0%
|
1,700
|
$45,000 | — | 30 Sep 2021 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1,246
|
$33,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,119
|
$30,000 | — | 30 Sep 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
872
|
$23,000 | — | 30 Sep 2021 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
774
|
$20,000 | — | 30 Sep 2021 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
634
|
$17,000 | — | 30 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
542
|
$14,000 | — | 30 Sep 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
233
|
$6,000 | — | 30 Sep 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
44
|
$1,000 | — | 30 Sep 2021 |
Institutional Holders of Immuneering Corp - Class A common stock, par value $0.001 per share (IMRX) as of Q4 2021
As of 31 Dec 2021,
Immuneering Corp - Class A common stock, par value $0.001 per share (IMRX) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,489,185 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, Cormorant Asset Management, LP, CITADEL ADVISORS LLC, BlackRock Inc., Rock Springs Capital Management LP, PERCEPTIVE ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, SUVRETTA CAPITAL MANAGEMENT, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
36
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
38
Q4 2021 holders
36
Holder diff
-2
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.